Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer’s disease

Tomohiro Nakamura,Chang-Ki Oh,Lujian Liao,Xu Zhang,Kevin M Lopez,Daniel Gibbs,Amanda K Deal,Henry R Scott,Brian Spencer,Eliezer Masliah,Robert A Rissman,John R Yates,Stuart A Lipton,Chang-ki Oh,Kevin M. Lopez,Amanda K. Deal,Henry R. Scott,Robert A. Rissman,John R. Yates,Stuart A. Lipton
DOI: https://doi.org/10.1126/science.aaw0843
IF: 56.9
2021-01-15
Science
Abstract:A cascade of NO in Alzheimer's disease One of the ill effects of the amyloid-β peptide that accumulates in Alzheimer's disease (AD) is the promotion of the production of nitric oxide (NO) and consequent nitrosylation of thiols in proteins such as dynamin-related protein 1 (Drp1), which can lead to loss of neuronal synapses. Nakamura et al. found that this S-nitrosylation occurs in an unusual way. They detected a series of transnitrosylation events in which an NO group is passed between at least three proteins. The deubiquinating enzyme Uch-L1 was S-nitrosylated in brains from human AD patients or in mouse models of AD. Uch-L1 could lead to S-nitrosylation of Drp1 after transferring the NO group to another enzyme, Cdk5 (cyclin-dependent kinase 5). The results implicate a mechanism in which unrelated enzymes might aberrantly function together to disrupt brain function. Science , this issue p. eaaw0843
multidisciplinary sciences
What problem does this paper attempt to address?